Our previously developed blood-based transcriptional risk scores (TRS) showed associations with diagnosis and neuroimaging biomarkers for Alzheimer’s disease (AD). Here, we developed brain-based TRS.
Our previously developed blood-based transcriptional risk scores (TRS) showed associations with diagnosis and neuroimaging biomarkers for Alzheimer’s disease (AD). Here, we developed brain-based TRS.